Showing results (1-10 of 169) with videos related to

Sort By:
Pageof 17
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1994
Plasma levels of a novel noncyclooxygenase-derived prostanoid (8-isoprostane) correlate with severity of liver injury in experimental alcoholic liver diseaseA A Nanji, S Khwaja, S R Tahan, et al.
Experimental and Molecular Pathology|February 1, 1995
Intercellular adhesion molecule-1 expression in experimental alcoholic liver disease: relationship to endotoxemia and TNF alpha messenger RNAA A Nanji, B Griniuviene, L K Yacoub, et al.
Gastroenterology|January 1, 1997
Thromboxane inhibitors attenuate pathological changes in alcoholic liver disease in the ratA A Nanji, S Khwaja, A Rahemtulla, et al.
The American Journal of Pathology|March 1, 1996
Role of transforming growth factor-[beta]1 in inhibiting endothelial cell proliferation in experimental alcoholic liver diseaseA A Nanji, S R Tahan, M Golding, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1997
Alterations in thromboxane synthase and thromboxane A2 receptors in experimental alcoholic liver diseaseA A Nanji, A Rahemtulla, L Maio, et al.
Alcoholism, Clinical and Experimental Research|October 1, 1994
Markedly enhanced cytochrome P450 2E1 induction and lipid peroxidation is associated with severe liver injury in fish oil-ethanol-fed ratsA A Nanji, S Zhao, S M Sadrzadeh, et al.
Pageof 17